Marijana Vanevski
Marijana Vanevski
Details
Role
Project Manager
Research area
Infection, Immunity and Global Health
Group
Clinical Infections
Ms Marijana Vanevski is the Project Manager for the Infections in Cancer team. She is also the Research Ethics Coordinator at the Centre for Population Genomics.
Ms Marijana Vanevski is the Project Manager for the Infections in Cancer team. She is also the Research Ethics Coordinator at the Centre for Population Genomics.
Top Publications
- Haeusler, GM, De Abreu Lourenco, R, Bakos, C, O'Brien, T, Slavin, MA, Clark, JE, McMullan, B, Borland, ML, Babl, FE, Krishnasamy, M, et al. Managing low‐risk febrile neutropenia in children in the time of COVID‐19: What matters to parents and clinicians. Journal of Paediatrics and Child Health 57(6) : 826 -834 2021 view publication
- Ball, D, Mai, GT, Vinod, S, Babington, S, Ruben, J, Kron, T, Chesson, B, Herschtal, A, Vanevski, M, Rezo, A, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. The Lancet Oncology 20(4) : 494 -503 2019 view publication
- Ball, D, Mai, GT, Vinod, S, Babington, S, Ruben, J, Kron, T, Chesson, B, Herschtal, A, Vanevski, M, Rezo, A, et al. 453O Quality of life in the CHISEL randomized trial of stereotactic ablative radiotherapy (SABR) versus standard radiotherapy for stage I non-small cell lung cancer (Trans-Tasman Radiation Oncology Group 09.02). Annals of Oncology 29: ix139 2018 view publication
- Ball, D, Mai, T, Vinod, S, Babington, S, Ruben, J, Kron, T, Chesson, B, Herschtal, A, Rezo, A, Elder, C, et al. MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL). Journal of Thoracic Oncology 12(11) : s1853 2017 view publication
- Michael, M, Chu, J, Bressel, M, McKendrick, J, Cooray, P, Chander, S, Jefford, M, Vanevski, M, Wong, R, Steel, M, et al. A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial.. Journal of Clinical Oncology 34(15_suppl) : 3613 -3613 2016 view publication
Page 1 of 2
Career information
Share //
